U.S. Markets closed

Recro Pharma, Inc. (REPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9200-0.0500 (-2.54%)
At close: 4:00PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts2222
Avg. Estimate-0.11-0.08-0.45-0.3
Low Estimate-0.13-0.1-0.52-0.33
High Estimate-0.09-0.06-0.38-0.28
Year Ago EPS-0.25-0.09-1.16-0.45
Revenue EstimateCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
No. of Analysts2222
Avg. Estimate17.1M17.99M69.88M76.41M
Low Estimate16.81M17.16M68.13M73.58M
High Estimate17.38M18.82M71.64M79.23M
Year Ago Sales15.52M19.29M66.5M69.88M
Sales Growth (year/est)10.20%-6.70%5.10%9.30%
Earnings History6/29/20209/29/202012/30/20203/30/2021
EPS Est.-0.16-0.2-0.22-0.25
EPS Actual-0.25-0.09-0.48-0.23
Difference-0.090.11-0.260.02
Surprise %-56.20%55.00%-118.20%8.00%
EPS TrendCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Current Estimate-0.11-0.08-0.45-0.3
7 Days Ago-0.11-0.08-0.45-0.14
30 Days Ago-0.11-0.08-0.45-0.14
60 Days Ago-0.14-0.08-0.62-0.18
90 Days Ago-0.13-0.08-0.58-0.18
EPS RevisionsCurrent Qtr. (Jun 2021)Next Qtr. (Sep 2021)Current Year (2021)Next Year (2022)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesREPHIndustrySector(s)S&P 500
Current Qtr.56.00%N/AN/AN/A
Next Qtr.11.10%N/AN/AN/A
Current Year61.20%N/AN/AN/A
Next Year33.30%N/AN/AN/A
Next 5 Years (per annum)15.00%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A